OA10173A - Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide - Google Patents

Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide Download PDF

Info

Publication number
OA10173A
OA10173A OA60690A OA60690A OA10173A OA 10173 A OA10173 A OA 10173A OA 60690 A OA60690 A OA 60690A OA 60690 A OA60690 A OA 60690A OA 10173 A OA10173 A OA 10173A
Authority
OA
OAPI
Prior art keywords
sait
lysine
oxindole
carboxamide
fluoro
Prior art date
Application number
OA60690A
Other languages
English (en)
Inventor
Kelvin Cooper
Bruce Crawford
Bruce Litman
Christopher Pazoles
Sally RUGGERI
Keith Wilner
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/007,217 external-priority patent/US5298522A/en
Application filed by Pfizer filed Critical Pfizer
Publication of OA10173A publication Critical patent/OA10173A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA60690A 1993-01-22 1995-07-21 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide OA10173A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/007,217 US5298522A (en) 1993-01-22 1993-01-22 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US13827793A 1993-10-18 1993-10-18

Publications (1)

Publication Number Publication Date
OA10173A true OA10173A (en) 1996-12-18

Family

ID=26676677

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60690A OA10173A (en) 1993-01-22 1995-07-21 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Country Status (27)

Country Link
EP (1) EP0680321B1 (fr)
JP (1) JP2711939B2 (fr)
CN (1) CN1116822A (fr)
AP (1) AP468A (fr)
AT (1) ATE171373T1 (fr)
AU (1) AU671533B2 (fr)
BG (1) BG61966B1 (fr)
BR (1) BR9405661A (fr)
CA (1) CA2153050C (fr)
CZ (1) CZ182895A3 (fr)
DE (1) DE69413518T2 (fr)
DK (1) DK0680321T3 (fr)
DZ (1) DZ1748A1 (fr)
ES (1) ES2122236T3 (fr)
FI (1) FI940309A7 (fr)
HU (1) HUT69687A (fr)
IL (1) IL108326A0 (fr)
LV (1) LV10920B (fr)
MA (1) MA23095A1 (fr)
NO (1) NO952904L (fr)
NZ (1) NZ261449A (fr)
OA (1) OA10173A (fr)
PL (1) PL309957A1 (fr)
SK (1) SK91395A3 (fr)
UY (1) UY23723A1 (fr)
WO (1) WO1994016694A1 (fr)
YU (1) YU48719B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022605A1 (fr) * 1995-12-19 1997-06-26 Pfizer Inc. Sels stables et a action prolongee de derives d'indole pour le traitement de maladies articulaires
EP0826685A1 (fr) * 1996-08-21 1998-03-04 Pfizer Inc. Sels de carboxamides stables à effet prolongé destinés au traitement des maladies articulaires
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio

Also Published As

Publication number Publication date
UY23723A1 (es) 1994-06-28
EP0680321A1 (fr) 1995-11-08
HUT69687A (en) 1995-09-28
BG99767A (bg) 1996-02-28
EP0680321B1 (fr) 1998-09-23
MA23095A1 (fr) 1994-10-01
BR9405661A (pt) 1995-11-21
FI940309A0 (fi) 1994-01-21
DE69413518D1 (en) 1998-10-29
AU6019894A (en) 1994-08-15
HU9400176D0 (en) 1994-05-30
NO952904D0 (no) 1995-07-21
DZ1748A1 (fr) 2002-02-17
AP9400609A0 (en) 1994-01-31
PL309957A1 (en) 1995-11-13
NO952904L (no) 1995-07-21
IL108326A0 (en) 1994-04-12
AU671533B2 (en) 1996-08-29
FI940309L (fi) 1994-07-23
DE69413518T2 (de) 1999-02-11
AP468A (en) 1996-03-05
ES2122236T3 (es) 1998-12-16
YU48719B (sh) 1999-07-28
JP2711939B2 (ja) 1998-02-10
WO1994016694A1 (fr) 1994-08-04
LV10920A (lv) 1995-12-20
YU2394A (sh) 1996-10-18
CZ182895A3 (en) 1996-01-17
DK0680321T3 (da) 1999-06-14
CN1116822A (zh) 1996-02-14
FI940309A7 (fi) 1994-07-23
JPH08501109A (ja) 1996-02-06
CA2153050A1 (fr) 1994-08-04
LV10920B (en) 1996-04-20
CA2153050C (fr) 1998-12-29
SK91395A3 (en) 1996-12-04
ATE171373T1 (de) 1998-10-15
BG61966B1 (bg) 1998-11-30
NZ261449A (en) 1996-08-27

Similar Documents

Publication Publication Date Title
EP1499589B1 (fr) Derives de n-¬phenyl(piperidin-2-yl)methyl|benzamide, leur preparation et leur application en therapeutique
AU653902B2 (en) 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1- carboxamide as an analgesic and anti-inflammatory agent
KR20040107520A (ko) (에스)-4-아미노-5-클로로-2-메톡시-엔-[1-[1-(2-테트라히드로푸릴카르보닐)-4-피페리디닐메틸]-4-피페리디닐]벤즈아미드, 그것의 제조방법, 그것을 함유하는 약제학적 조성물,및 그것을 위한 중간체
KR100513302B1 (ko) 3-아미노-1,2-벤조이소옥사졸 유도체, 이의 제조방법및 용도
JPH09510222A (ja) ２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピン化合物の酸付加塩
US6066667A (en) Substituted furanones, compositions and antiarthritic use
HU194159B (en) Process for preparing n- square brackets open 6-methoxy-5- /perfluoroalkyl/-1-naphtoyl square brackets closed -n-methylglycines and their thionaphtyl analogues and pharmaceuticals comprising such active substance
JPH05504970A (ja) 尿素誘導体類、それらの製造およびそれらを含有している薬用生成物
JPH08283219A (ja) アラルキルアミノアルキルアミド誘導体
OA10173A (en) Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide
US4448786A (en) 4-Naphthyl and substituted naphthyl-3-hydroxy-3-pyrroline-2,5-diones and their use as inhibitors of glycolic acid oxidase
US5912261A (en) Carboxyalkyl heterocyclic derivatives
US4465692A (en) Selective D-2 dopamine receptor agonist
JPS61286359A (ja) Ｎ−〔〔５−（トリフルオロメチル）−６−メトキシ−１−ナフタレニル〕チオキソメチルまたはカルボニル〕−ｎ−メチルグリシンアミド
DE68909757T2 (de) Indanderivate, Verfahren zu ihrer Herstellung und erhaltene Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen.
EP0395526B1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US4539317A (en) 4-Substituted amino-3-[3-alkylindoloamino-2-hydroxypropoxy] thiadiazoles, compositions and pharmaceutical use
KR100556559B1 (ko) 2-(4-(4-(4,5-디클로로-2-메틸이미다졸-1-일)부틸)-1-피페라지닐)-5-플루오로피리미딘, 이것의 제조 방법 및 이것의치료적 용도
WO1997027175A1 (fr) DERIVES D'ETHER D'ETHYLE α,α - DIARYLMETHYLE A SUBSTITUTION
KR850000844B1 (ko) 피롤리딘 유도체의 제조방법
SI9400099A (sl) Lizinova sol 6-kloro-5-fluoro-3-{2-tenoil)-2-oksindol-1-karboksiamida
LU82394A1 (fr) Nouvelles quinazolines,leur procede de production et medicament les contenant
WO2006032165A1 (fr) Nouveaux composés n-hétérocycliques substitués à cinq chaînons, et utilisation desdits composés dans le traitement des maladies liées au vieillissement des protéines